Literature DB >> 27931771

Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.

Yury I Miller1, John Y-J Shyy2.   

Abstract

Oxidized low-density lipoprotein (OxLDL), which contains hundreds of different oxidized lipid molecules, is a hallmark of hyperlipidemia and atherosclerosis. The same oxidized lipids found in OxLDL are also formed in apoptotic cells, and are present in tissues as well as in the circulation under pathological conditions. In many disease contexts, oxidized lipids constitute damage signals, or patterns, that activate pattern-recognition receptors (PRRs) and significantly contribute to inflammation. Here, we review recent discoveries and emerging trends in the field of oxidized lipids and the regulation of inflammation, focusing on oxidation products of polyunsaturated fatty acids esterified into cholesteryl esters (CEs) and phospholipids (PLs). We also highlight context-dependent activation and biased agonism of Toll-like receptor-4 (TLR4) and the NLRP3 inflammasome, among other signaling pathways activated by oxidized lipids.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  inflammasome; inflammation; oxidized lipid; toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 27931771      PMCID: PMC5253098          DOI: 10.1016/j.tem.2016.11.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  86 in total

Review 1.  Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.

Authors:  Yury I Miller; Sotirios Tsimikas
Journal:  Curr Opin Lipidol       Date:  2013-10       Impact factor: 4.776

2.  Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.

Authors:  Valery N Bochkov; Diana Mechtcheriakova; Marcus Lucerna; Joakim Huber; Roland Malli; Wolfgang F Graier; Erhard Hofer; Bernd R Binder; Norbert Leitinger
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

3.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

4.  Increased transcription of IL-8 in endothelial cells is differentially regulated by TNF-alpha and oxidized phospholipids.

Authors:  M Yeh; N Leitinger; R de Martin; N Onai; K Matsushima; D K Vora; J A Berliner; S T Reddy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

Review 5.  Nrf2 in health and disease: current and future clinical implications.

Authors:  Othman Al-Sawaf; Tim Clarner; Athanassios Fragoulis; Yuet Wai Kan; Thomas Pufe; Konrad Streetz; Christoph Jan Wruck
Journal:  Clin Sci (Lond)       Date:  2015-12       Impact factor: 6.124

6.  Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection.

Authors:  Graciela Andonegui; Hong Zhou; Daniel Bullard; Margaret M Kelly; Sarah C Mullaly; Braedon McDonald; Elizabeth M Long; Stephen M Robbins; Paul Kubes
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

7.  Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.

Authors:  Soumya Panigrahi; Yi Ma; Li Hong; Detao Gao; Xiaoxia Z West; Robert G Salomon; Tatiana V Byzova; Eugene A Podrez
Journal:  Circ Res       Date:  2012-10-15       Impact factor: 17.367

8.  Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.

Authors:  Clett Erridge; Simon Kennedy; Corinne M Spickett; David J Webb
Journal:  J Biol Chem       Date:  2008-06-17       Impact factor: 5.157

9.  Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation.

Authors:  Olga V Oskolkova; Taras Afonyushkin; Beatrix Preinerstorfer; Wolfgang Bicker; Elena von Schlieffen; Eva Hainzl; Svitlana Demyanets; Gernot Schabbauer; Wolfgang Lindner; Alexandros D Tselepis; Johann Wojta; Bernd R Binder; Valery N Bochkov
Journal:  J Immunol       Date:  2010-11-10       Impact factor: 5.422

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  32 in total

1.  Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Authors:  Alexander V Sorokin; Kazuhiko Kotani; Youssef A Elnabawi; Amit K Dey; Aparna P Sajja; Shingo Yamada; Masashi Ueda; Charlotte L Harrington; Yvonne Baumer; Justin A Rodante; Joel M Gelfand; Marcus Y Chen; Aditya A Joshi; Martin P Playford; Alan T Remaley; Nehal N Mehta
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

2.  A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.

Authors:  Ayelet Gonen; Soo-Ho Choi; Phuong Miu; Colin Agatisa-Boyle; Daniel Acks; Angela M Taylor; Coleen A McNamara; Sotirios Tsimikas; Joseph L Witztum; Yury I Miller
Journal:  J Lipid Res       Date:  2018-12-18       Impact factor: 5.922

Review 3.  Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3.

Authors:  Jingxue Ye; Lanfang Li; Min Wang; Qiuxiao Ma; Yu Tian; Qiong Zhang; Jiushi Liu; Bin Li; Bengang Zhang; Haitao Liu; Guibo Sun
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

Review 4.  AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis.

Authors:  Xueting Qiu; Jingmin Luo; Longhou Fang
Journal:  Curr Atheroscler Rep       Date:  2020-11-24       Impact factor: 5.113

5.  Cooking Oil Consumption Is Positively Associated with Risk of Type 2 Diabetes in a Chinese Nationwide Cohort Study.

Authors:  Pan Zhuang; Lei Mao; Fei Wu; Jun Wang; Jingjing Jiao; Yu Zhang
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

Review 6.  The Weight of Obesity in Immunity from Influenza to COVID-19.

Authors:  Fernanda B Andrade; Ana Gualberto; Camila Rezende; Nathércia Percegoni; Jacy Gameiro; Eugenio D Hottz
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

Review 7.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

8.  Minimally Oxidized-LDL-Driven Alterations in the Level of Pathological Mediators and Biological Processes in Carotid Atherosclerosis.

Authors:  Finosh G Thankam; Taj Rai; Jeffrey Liu; Jonathan Tam; Devendra K Agrawal
Journal:  Cardiol Cardiovasc Med       Date:  2022-04-12

Review 9.  Oxidative Cysteine Modification of Thiol Isomerases in Thrombotic Disease: A Hypothesis.

Authors:  Moua Yang; Robert Flaumenhaft
Journal:  Antioxid Redox Signal       Date:  2021-09-13       Impact factor: 8.401

10.  Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors.

Authors:  Shihao Xu; Omkar Chaudhary; Patricia Rodríguez-Morales; Xiaoli Sun; Dan Chen; Roberta Zappasodi; Ziyan Xu; Antonio F M Pinto; April Williams; Isabell Schulze; Yagmur Farsakoglu; Siva Karthik Varanasi; Jun Siong Low; Wenxi Tang; Haiping Wang; Bryan McDonald; Victoria Tripple; Michael Downes; Ronald M Evans; Nada A Abumrad; Taha Merghoub; Jedd D Wolchok; Maxim N Shokhirev; Ping-Chih Ho; Joseph L Witztum; Brinda Emu; Guoliang Cui; Susan M Kaech
Journal:  Immunity       Date:  2021-06-07       Impact factor: 43.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.